eLaws | eCases | United States Code | Federal Courts |

Novartis Pharmaceuticals Corp. - Comment

Document ID: FDA-2013-N-0222-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: May 07 2013, at 12:00 AM Eastern Daylight Time
Date Posted: May 21 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: March 18 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: May 17 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-8571-3il1
View Document:

This is comment on Notice

International Conference on Harmonisation: Proposed Change to Rodent Carcinogenicity Testing of Pharmaceuticals

View Comment

See attached file(s)

Attachments:

Novartis Pharmaceuticals Corp Comment ICHS1FDA Comments PCS Final

Title:
Novartis Pharmaceuticals Corp Comment ICHS1FDA Comments PCS Final

View Attachment:

View as format pdf

Related Comments

View All

Total: 11

American Chemistry Council (ACC) - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0222-0006

Comment Period Closed
May 17,2013 11:59 PM ET

Bristol-Myers Squibb - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0222-0007

Comment Period Closed
May 17,2013 11:59 PM ET

Society of Toxicologic Pathology - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0222-0002

Comment Period Closed
May 17,2013 11:59 PM ET

Novartis Pharmaceuticals Corp. - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0222-0004

Comment Period Closed
May 17,2013 11:59 PM ET

BioReliance - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0222-0010

Comment Period Closed
May 17,2013 11:59 PM ET